Nefazodone Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01149 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | atrophoderma vermiculata | KG + DL |
| 4 | myofascial pain syndrome | KG + DL |
| 5 | ulerythema ophryogenesis | KG + DL |
| 6 | Ohdo syndrome and variants | KG + DL |
| 7 | migraine with or without aura, susceptibility to | KG + DL |
| 8 | manic bipolar affective disorder | KG + DL |
| 9 | osteoarthritis susceptibility | KG + DL |
| 10 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 11 | nicotine dependence | KG + DL |
| 12 | attention deficit-hyperactivity disorder | KG + DL |
| 13 | childhood apraxia of speech | KG + DL |
| 14 | trichotillomania | KG + DL |
| 15 | faciodigitogenital syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.